Transforming Global HEOR & RWE Operations: From Fragmentation to Full Transparency

CHALLENGE 

A top-10 pharmaceutical company needed to better coordinate its global Health Economics and Outcomes Research (HEOR) and Real-World Evidence (RWE) initiatives to support the value story of a key oncology therapy. Studies were being conducted across multiple regions and vendors with inconsistent timelines, fragmented data reporting, and limited communication between global and affiliate teams. As a result, leadership lacked a clear view of study progress, deliverables, and budgets – hindering their ability to translate real-world evidence into actionable insights for market access and publication planning. 

SOLUTION 

CMK Select engaged a senior consultant with deep HEOR and RWE program management expertise to bring structure and visibility to the portfolio. Acting as a single point of accountability, the consultant implemented standardized tracking tools, established clear governance processes, and coordinated cross-functional meetings between medical, access, and regional evidence leads. Vendor reporting was streamlined, milestone forecasting improved, and a centralized dashboard was introduced to monitor study status and spend. This leadership approach enabled consistent communication and faster decision-making across stakeholders. 

IMPACT & VALUE REALIZED 

The client gained full transparency into more than 30 active evidence-generation projects, with reporting accuracy and timeliness improving by 25%. Consolidated oversight led to more efficient study execution, faster delivery of payer evidence packages, and stronger alignment between global and affiliate teams. With CMK Select’s dedicated consultant driving structure, accountability, and insight, the company transformed its HEOR and RWE operations into a cohesive, strategically managed program that delivers measurable value.